WEBSITE BSE:0 NSE: Inc. Year: 1996 Industry: Electrodes & Welding Equipment My Bucket: Add Stock
Last updated: 15:29
No Notes Added Yet
Royal Arc Electrodes Ltd, established in 1996 and headquartered in Mumbai, Maharashtra, is a leading manufacturer of welding consumables in India. The company specializes in producing welding electrodes, flux-cored wires, MIG/TIG wires, and strip cladding materials. These products are essential for welding applications in various industries, including railways, roadways, airport infrastructure, refineries, shipyards, mines, sugar industries, telecom sectors, thermal power stations, and pre-engineered buildings. Royal Arc operates a state-of-the...Read More
Royal Arc Electrodes Ltd, established in 1996 and headquartered in Mumbai, Maharashtra, is a leading manufacturer of welding consumables in India. The company specializes in producing welding electrodes, flux-cored wires, MIG/TIG wires, and strip cladding materials. These products are essential for welding applications in various industries, including railways, roadways, airport infrastructure, refineries, shipyards, mines, sugar industries, telecom sectors, thermal power stations, and pre-engineered buildings. Royal Arc operates a state-of-the-art manufacturing facility spanning over 25,000 square meters in Gujarat, equipped with advanced laboratories for chemical, mechanical, and spectro testing. The company is ISO 9001:2015 certified and holds approvals from organizations such as ABS, IBR, and BIS, ensuring compliance with international quality standards. With a strong presence in over 20 countries, Royal Arc has established itself as a trusted supplier of welding consumables globally. The company maintains a robust distribution network and has built long-term relationships with clients across various sectors. ...Read Less
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Market Cap ₹178 Cr.
Stock P/E 19.7
P/B 2.5
Current Price ₹160
Book Value ₹ 64.7
Face Value 10
52W High ₹185
Dividend Yield 0%
52W Low ₹ 126.5
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) |
|---|
| Net Sales |
| Other Income |
| Total Income |
| Total Expenditure |
| Operating Profit |
| Interest |
| Depreciation |
| Exceptional Income / Expenses |
| Profit Before Tax |
| Provision for Tax |
| Profit After Tax |
| Adjustments |
| Profit After Adjustments |
| Adjusted Earnings Per Share |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 65 | 64 | 64 | 68 | 76 | 65 | 43 | 63 | 97 | 100 | 102 | |
| Other Income | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 2 | 1 | 1 | 1 | |
| Total Income | 65 | 64 | 64 | 68 | 76 | 66 | 46 | 65 | 98 | 101 | 102 | |
| Total Expenditure | 59 | 58 | 59 | 63 | 71 | 61 | 41 | 59 | 83 | 83 | 87 | |
| Operating Profit | 6 | 6 | 5 | 5 | 5 | 5 | 5 | 6 | 16 | 18 | 16 | |
| Interest | 3 | 3 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 0 | 0 | |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | |
| Profit Before Tax | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 13 | 16 | 12 | |
| Provision for Tax | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 3 | 4 | 3 | |
| Profit After Tax | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 10 | 12 | 9 | |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Profit After Adjustments | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 10 | 12 | 9 | |
| Adjusted Earnings Per Share | 1 | 1.3 | 1.1 | 1.5 | 1.4 | 1.3 | 1.7 | 2.3 | 10.3 | 13 | 8.1 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 2% | 17% | 9% | 5% |
| Operating Profit CAGR | -11% | 39% | 26% | 10% |
| PAT CAGR | -25% | 65% | 55% | 25% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 3% | NA% | NA% | NA% |
| ROE Average | 16% | 29% | 23% | 15% |
| ROCE Average | 21% | 37% | 30% | 19% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 11 | 12 | 13 | 15 | 16 | 17 | 19 | 21 | 30 | 42 | 72 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 16 | 13 | 11 | 11 | 8 | 4 | 3 | 2 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 2 | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 |
| Total Current Liabilities | 22 | 20 | 21 | 26 | 26 | 16 | 15 | 18 | 11 | 8 | 8 |
| Total Liabilities | 52 | 48 | 48 | 53 | 52 | 39 | 40 | 42 | 44 | 52 | 81 |
| Fixed Assets | 21 | 18 | 18 | 18 | 16 | 15 | 16 | 15 | 14 | 16 | 20 |
| Other Non-Current Assets | 2 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 2 | 4 | 5 |
| Total Current Assets | 29 | 29 | 29 | 34 | 34 | 24 | 23 | 27 | 28 | 32 | 57 |
| Total Assets | 52 | 48 | 48 | 53 | 52 | 39 | 40 | 42 | 44 | 52 | 81 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 4 | 0 | 1 | 1 | 4 | 2 | 1 | 0 | 0 | 3 | 1 |
| Cash Flow from Operating Activities | 7 | 0 | 6 | 3 | 5 | 6 | 7 | 2 | 13 | 6 | 4 |
| Cash Flow from Investing Activities | -8 | 0 | -2 | -1 | -0 | 1 | -3 | -1 | -2 | -6 | -7 |
| Cash Flow from Financing Activities | -1 | 0 | -5 | 1 | -6 | -8 | -5 | -2 | -7 | -2 | 21 |
| Net Cash Inflow / Outflow | -2 | 0 | -0 | 3 | -1 | -2 | -0 | -0 | 3 | -2 | 18 |
| Closing Cash & Cash Equivalent | 1 | 0 | 1 | 4 | 2 | 1 | 0 | 0 | 3 | 1 | 19 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 1.04 | 1.27 | 1.13 | 1.54 | 1.35 | 1.28 | 1.69 | 2.28 | 10.29 | 13.04 | 8.11 |
| CEPS(Rs) | 2.88 | 3.14 | 2.94 | 3.49 | 3.25 | 3.11 | 3.49 | 4.19 | 12.27 | 14.99 | 10.77 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 12.02 | 13.29 | 14.42 | 15.96 | 17.31 | 18.6 | 20.29 | 22.34 | 32.63 | 45.49 | 64.66 |
| Core EBITDA Margin(%) | 8.06 | 8.09 | 7.06 | 7.27 | 6.75 | 5.4 | 6.31 | 5.79 | 14.86 | 17.31 | 14.83 |
| EBIT Margin(%) | 6.11 | 6.15 | 5 | 5.35 | 4.59 | 4.72 | 7.56 | 6.01 | 14.09 | 16.39 | 12.04 |
| Pre Tax Margin(%) | 2.16 | 2.46 | 2.28 | 2.54 | 2.33 | 2.41 | 4.99 | 4.46 | 13.47 | 16.29 | 11.83 |
| PAT Margin (%) | 1.36 | 1.64 | 1.5 | 2.08 | 1.66 | 1.85 | 3.63 | 3.37 | 9.87 | 12.12 | 8.85 |
| Cash Profit Margin (%) | 3.78 | 4.07 | 3.89 | 4.72 | 3.99 | 4.48 | 7.5 | 6.19 | 11.77 | 13.92 | 11.75 |
| ROA(%) | 1.95 | 2.35 | 2.18 | 2.82 | 2.39 | 2.61 | 3.98 | 9.99 | 22.17 | 25.24 | 13.53 |
| ROE(%) | 9.01 | 10.01 | 8.19 | 10.13 | 8.13 | 7.14 | 8.7 | 20.42 | 37.43 | 33.39 | 15.79 |
| ROCE(%) | 11.88 | 11.66 | 9.86 | 9.78 | 9.07 | 9.23 | 11.58 | 26.46 | 45.27 | 44.19 | 21.29 |
| Receivable days | 49.96 | 52.45 | 60.07 | 69.25 | 66.71 | 70.39 | 90.85 | 75.93 | 55.58 | 67.66 | 74.62 |
| Inventory Days | 61.13 | 67.1 | 65.86 | 69.55 | 68.97 | 72.88 | 82.75 | 62.89 | 31.83 | 27.54 | 41.83 |
| Payable days | 37.56 | 0 | 0 | 0 | 0 | 0 | 48.86 | 39.72 | 49.14 | 36.46 | 26.7 |
| PER(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 18.62 |
| Price/Book(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.34 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.44 | 0.38 | 0.35 | 0.35 | 0.26 | 0.21 | 0.23 | 0.15 | 0 | 0.09 | 1.47 |
| EV/Core EBITDA(x) | 4.72 | 3.97 | 4.31 | 4.26 | 3.76 | 2.8 | 1.97 | 1.72 | 0.01 | 0.47 | 9.5 |
| Net Sales Growth(%) | 7.93 | -1.81 | -0.04 | 5.88 | 12.15 | -14.84 | -32.87 | 0 | 54.09 | 3.27 | 1.66 |
| EBIT Growth(%) | 14.11 | 1.65 | -20.34 | 4.72 | -5.35 | -12.52 | 7.6 | 0 | 261.15 | 20.11 | -25.33 |
| PAT Growth(%) | 22.98 | 21.9 | -10.47 | 35.73 | -12.19 | -5.23 | 31.93 | 0 | 351.05 | 26.76 | -25.75 |
| EPS Growth(%) | 22.98 | 21.9 | -10.47 | 35.73 | -12.19 | -5.23 | 31.93 | 34.93 | 351.05 | 26.76 | -37.79 |
| Debt/Equity(x) | 2.52 | 1.94 | 1.61 | 1.71 | 1.26 | 0.71 | 0.44 | 0.38 | 0.05 | 0 | 0.01 |
| Current Ratio(x) | 1.3 | 1.41 | 1.37 | 1.32 | 1.34 | 1.48 | 1.54 | 1.49 | 2.51 | 3.78 | 7.39 |
| Quick Ratio(x) | 0.7 | 0.78 | 0.78 | 0.79 | 0.76 | 0.81 | 0.97 | 0.89 | 1.97 | 2.71 | 5.53 |
| Interest Cover(x) | 1.55 | 1.66 | 1.84 | 1.9 | 2.03 | 2.05 | 2.94 | 3.88 | 22.46 | 165.92 | 56.99 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| # | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|
| Promoter | 72.96 | 72.96 | 72.96 |
| FII | 7.14 | 5.24 | 5.57 |
| DII | 0.19 | 0 | 0 |
| Public | 19.71 | 21.79 | 21.47 |
| Others | 0 | 0 | 0 |
| Total | 100 | 100 | 100 |
| # | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|
| Promoter | 0.81 | 0.81 | 0.81 |
| FII | 0.08 | 0.06 | 0.06 |
| DII | 0 | 0 | 0 |
| Public | 0.22 | 0.24 | 0.24 |
| Others | 0 | 0 | 0 |
| Total | 1.11 | 1.11 | 1.11 |
* The pros and cons are machine generated.
You May Also Know About
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
ChatGPT
Claude
Perplexity
